Due to the high concentration of MDR-1 (drug-resistant gene) in renal carcinoma cells, its product P-glycoprotein (p170) can pump chemotherapeutic drugs out of tumor cells; thus, traditional chemotherapy drugs are mostly ineffective for renal carcinoma [33]. This evidence concerns the gene ABCB1 and renal carcinoma.